Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(13 sites)
United States
AdventHealth Orlando, Orlando, Florida Emory University, Atlanta, Georgia Indiana University Simon Comprehensive Cancer Center, Indianapolis, Indiana Norton Cancer Institute, Louisville, Kentucky The University of Texas MD Anderson Cancer Center, Houston, Texas Hong Kong
Queen Mary Hospital, Hong Kong Taiwan
Kaohsiung Chang-Gung Memorial Hospital, Kaohsiung City Ministry of Health and Welfare Shuang-Ho Hospital, New Taipei City Tamsui MacKay Memorial Hospital, New Taipei City Taichung Veterans General Hospital, Taichung National Cheng Kung University Hospital, Tainan National Taiwan University Hospital, Taipei Linkou Chang-Gung Memorial Hospital, Taoyuan